 | • レポートコード：MRC2-11QY11194 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は乳癌治療のグローバル市場について調査・分析したレポートです。種類別（フェーズI治療、フェーズII治療、フェーズIII治療）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別乳癌治療の競争状況、市場シェア ・世界の乳癌治療市場：種類別市場規模 2015年-2020年（フェーズI治療、フェーズII治療、フェーズIII治療） ・世界の乳癌治療市場：種類別市場規模予測 2021年-2026年（フェーズI治療、フェーズII治療、フェーズIII治療） ・世界の乳癌治療市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診断センター） ・世界の乳癌治療市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診断センター） ・北米の乳癌治療市場分析：米国、カナダ ・ヨーロッパの乳癌治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの乳癌治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の乳癌治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの乳癌治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Eisai、Eli Lilly and Company、F. Hoffmann-La Roche、GlaxoSmithKline、Novartis International AG、Pfizer、Puma Biotechnology、Sanofi S.A.、Teva Pharmaceutical Industries ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Breast Cancer Therapeutic Market
The global Breast Cancer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Breast Cancer Therapeutic Scope and Market Size
Breast Cancer Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca
Eisai
Eli Lilly and Company
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis International AG
Pfizer
Puma Biotechnology
Sanofi S.A.
Teva Pharmaceutical Industries
Market segment by Type, the product can be split into
Phase I Treatment
Phase II Treatment
Phase III Treatment
Market segment by Application, split into
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Breast Cancer Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Breast Cancer Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Phase I Treatment
1.4.3 Phase II Treatment
1.4.4 Phase III Treatment
1.5 Market by Application
1.5.1 Global Breast Cancer Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Center
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Therapeutic Market Perspective (2015-2026)
2.2 Global Breast Cancer Therapeutic Growth Trends by Regions
2.2.1 Breast Cancer Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Breast Cancer Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Breast Cancer Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Breast Cancer Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Breast Cancer Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Therapeutic Players by Market Size
3.1.1 Global Top Breast Cancer Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Breast Cancer Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Breast Cancer Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Breast Cancer Therapeutic Market Concentration Ratio
3.2.1 Global Breast Cancer Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Therapeutic Revenue in 2019
3.3 Breast Cancer Therapeutic Key Players Head office and Area Served
3.4 Key Players Breast Cancer Therapeutic Product Solution and Service
3.5 Date of Enter into Breast Cancer Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Breast Cancer Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Breast Cancer Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Breast Cancer Therapeutic Market Size by Application (2015-2020)
5.2 Global Breast Cancer Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Breast Cancer Therapeutic Market Size (2015-2020)
6.2 Breast Cancer Therapeutic Key Players in North America (2019-2020)
6.3 North America Breast Cancer Therapeutic Market Size by Type (2015-2020)
6.4 North America Breast Cancer Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Breast Cancer Therapeutic Market Size (2015-2020)
7.2 Breast Cancer Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Breast Cancer Therapeutic Market Size by Type (2015-2020)
7.4 Europe Breast Cancer Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Breast Cancer Therapeutic Market Size (2015-2020)
8.2 Breast Cancer Therapeutic Key Players in China (2019-2020)
8.3 China Breast Cancer Therapeutic Market Size by Type (2015-2020)
8.4 China Breast Cancer Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Breast Cancer Therapeutic Market Size (2015-2020)
9.2 Breast Cancer Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Breast Cancer Therapeutic Market Size by Type (2015-2020)
9.4 Japan Breast Cancer Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Breast Cancer Therapeutic Market Size (2015-2020)
10.2 Breast Cancer Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Breast Cancer Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Breast Cancer Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Breast Cancer Therapeutic Market Size (2015-2020)
11.2 Breast Cancer Therapeutic Key Players in India (2019-2020)
11.3 India Breast Cancer Therapeutic Market Size by Type (2015-2020)
11.4 India Breast Cancer Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Breast Cancer Therapeutic Market Size (2015-2020)
12.2 Breast Cancer Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Breast Cancer Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Breast Cancer Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Breast Cancer Therapeutic Introduction
13.1.4 AstraZeneca Revenue in Breast Cancer Therapeutic Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Eisai
13.2.1 Eisai Company Details
13.2.2 Eisai Business Overview
13.2.3 Eisai Breast Cancer Therapeutic Introduction
13.2.4 Eisai Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.2.5 Eisai Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview
13.3.3 Eli Lilly and Company Breast Cancer Therapeutic Introduction
13.3.4 Eli Lilly and Company Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Details
13.4.2 F. Hoffmann-La Roche Business Overview
13.4.3 F. Hoffmann-La Roche Breast Cancer Therapeutic Introduction
13.4.4 F. Hoffmann-La Roche Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Breast Cancer Therapeutic Introduction
13.5.4 GlaxoSmithKline Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Novartis International AG
13.6.1 Novartis International AG Company Details
13.6.2 Novartis International AG Business Overview
13.6.3 Novartis International AG Breast Cancer Therapeutic Introduction
13.6.4 Novartis International AG Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.6.5 Novartis International AG Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Breast Cancer Therapeutic Introduction
13.7.4 Pfizer Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Puma Biotechnology
13.8.1 Puma Biotechnology Company Details
13.8.2 Puma Biotechnology Business Overview
13.8.3 Puma Biotechnology Breast Cancer Therapeutic Introduction
13.8.4 Puma Biotechnology Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.8.5 Puma Biotechnology Recent Development
13.9 Sanofi S.A.
13.9.1 Sanofi S.A. Company Details
13.9.2 Sanofi S.A. Business Overview
13.9.3 Sanofi S.A. Breast Cancer Therapeutic Introduction
13.9.4 Sanofi S.A. Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.9.5 Sanofi S.A. Recent Development
13.10 Teva Pharmaceutical Industries
13.10.1 Teva Pharmaceutical Industries Company Details
13.10.2 Teva Pharmaceutical Industries Business Overview
13.10.3 Teva Pharmaceutical Industries Breast Cancer Therapeutic Introduction
13.10.4 Teva Pharmaceutical Industries Revenue in Breast Cancer Therapeutic Business (2015-2020)
13.10.5 Teva Pharmaceutical Industries Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Breast Cancer Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Breast Cancer Therapeutic Revenue
Table 3. Ranking of Global Top Breast Cancer Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Breast Cancer Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Phase I Treatment
Table 6. Key Players of Phase II Treatment
Table 7. Key Players of Phase III Treatment
Table 8. Global Breast Cancer Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Breast Cancer Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Breast Cancer Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Breast Cancer Therapeutic Market Share by Regions (2015-2020)
Table 12. Global Breast Cancer Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Breast Cancer Therapeutic Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Breast Cancer Therapeutic Market Growth Strategy
Table 18. Main Points Interviewed from Key Breast Cancer Therapeutic Players
Table 19. Global Breast Cancer Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 20. Global Breast Cancer Therapeutic Market Share by Players (2015-2020)
Table 21. Global Top Breast Cancer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Therapeutic as of 2019)
Table 22. Global Breast Cancer Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Breast Cancer Therapeutic Product Solution and Service
Table 25. Date of Enter into Breast Cancer Therapeutic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 28. Global Breast Cancer Therapeutic Market Size Share by Type (2015-2020)
Table 29. Global Breast Cancer Therapeutic Revenue Market Share by Type (2021-2026)
Table 30. Global Breast Cancer Therapeutic Market Size Share by Application (2015-2020)
Table 31. Global Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 32. Global Breast Cancer Therapeutic Market Size Share by Application (2021-2026)
Table 33. North America Key Players Breast Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Breast Cancer Therapeutic Market Share (2019-2020)
Table 35. North America Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 36. North America Breast Cancer Therapeutic Market Share by Type (2015-2020)
Table 37. North America Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 38. North America Breast Cancer Therapeutic Market Share by Application (2015-2020)
Table 39. Europe Key Players Breast Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Breast Cancer Therapeutic Market Share (2019-2020)
Table 41. Europe Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Breast Cancer Therapeutic Market Share by Type (2015-2020)
Table 43. Europe Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Breast Cancer Therapeutic Market Share by Application (2015-2020)
Table 45. China Key Players Breast Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 46. China Key Players Breast Cancer Therapeutic Market Share (2019-2020)
Table 47. China Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 48. China Breast Cancer Therapeutic Market Share by Type (2015-2020)
Table 49. China Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 50. China Breast Cancer Therapeutic Market Share by Application (2015-2020)
Table 51. Japan Key Players Breast Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Breast Cancer Therapeutic Market Share (2019-2020)
Table 53. Japan Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Breast Cancer Therapeutic Market Share by Type (2015-2020)
Table 55. Japan Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Breast Cancer Therapeutic Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Breast Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Breast Cancer Therapeutic Market Share (2019-2020)
Table 59. Southeast Asia Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Breast Cancer Therapeutic Market Share by Type (2015-2020)
Table 61. Southeast Asia Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Breast Cancer Therapeutic Market Share by Application (2015-2020)
Table 63. India Key Players Breast Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 64. India Key Players Breast Cancer Therapeutic Market Share (2019-2020)
Table 65. India Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 66. India Breast Cancer Therapeutic Market Share by Type (2015-2020)
Table 67. India Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 68. India Breast Cancer Therapeutic Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Breast Cancer Therapeutic Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Breast Cancer Therapeutic Market Share (2019-2020)
Table 71. Central & South America Breast Cancer Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Breast Cancer Therapeutic Market Share by Type (2015-2020)
Table 73. Central & South America Breast Cancer Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Breast Cancer Therapeutic Market Share by Application (2015-2020)
Table 75. AstraZeneca Company Details
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca Product
Table 78. AstraZeneca Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 79. AstraZeneca Recent Development
Table 80. Eisai Company Details
Table 81. Eisai Business Overview
Table 82. Eisai Product
Table 83. Eisai Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 84. Eisai Recent Development
Table 85. Eli Lilly and Company Company Details
Table 86. Eli Lilly and Company Business Overview
Table 87. Eli Lilly and Company Product
Table 88. Eli Lilly and Company Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 89. Eli Lilly and Company Recent Development
Table 90. F. Hoffmann-La Roche Company Details
Table 91. F. Hoffmann-La Roche Business Overview
Table 92. F. Hoffmann-La Roche Product
Table 93. F. Hoffmann-La Roche Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 94. F. Hoffmann-La Roche Recent Development
Table 95. GlaxoSmithKline Company Details
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 99. GlaxoSmithKline Recent Development
Table 100. Novartis International AG Company Details
Table 101. Novartis International AG Business Overview
Table 102. Novartis International AG Product
Table 103. Novartis International AG Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 104. Novartis International AG Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. Puma Biotechnology Business Overview
Table 111. Puma Biotechnology Product
Table 112. Puma Biotechnology Company Details
Table 113. Puma Biotechnology Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 114. Puma Biotechnology Recent Development
Table 115. Sanofi S.A. Company Details
Table 116. Sanofi S.A. Business Overview
Table 117. Sanofi S.A. Product
Table 118. Sanofi S.A. Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 119. Sanofi S.A. Recent Development
Table 120. Teva Pharmaceutical Industries Company Details
Table 121. Teva Pharmaceutical Industries Business Overview
Table 122. Teva Pharmaceutical Industries Product
Table 123. Teva Pharmaceutical Industries Revenue in Breast Cancer Therapeutic Business (2015-2020) (Million US$)
Table 124. Teva Pharmaceutical Industries Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Phase I Treatment Features
Figure 3. Phase II Treatment Features
Figure 4. Phase III Treatment Features
Figure 5. Global Breast Cancer Therapeutic Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Center Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Breast Cancer Therapeutic Report Years Considered
Figure 10. Global Breast Cancer Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Breast Cancer Therapeutic Market Share by Regions: 2020 VS 2026
Figure 12. Global Breast Cancer Therapeutic Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Breast Cancer Therapeutic Market Share by Players in 2019
Figure 15. Global Top Breast Cancer Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Therapeutic as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Therapeutic Revenue in 2019
Figure 17. North America Breast Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Breast Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Breast Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Breast Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Breast Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Breast Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Breast Cancer Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
トリプルネガティブ乳がん治療の世界市場（～2026年） Market Analysis and Insights: Global Triple-Negative Breast Cancer Treatment Market The global Triple-Negative Breast Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Triple-Negative Breast Cancer Treat…- HER2陰性乳がん治療の世界市場（～2026年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
- 乳癌スクリーニング検査の世界市場（～2026年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…
- 乳癌リキッドバイオプシーの世界市場（～2026年） Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. Market Analysis and Insights: Global Breast Cancer …
- 転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…